Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Growth Metrics

Others

Avidity Biosciences, Inc. (RNA) Exchange Rate Effect (2025)

Avidity Biosciences' Exchange Rate Effect history spans 1 years, with the latest figure at -$1000.0 for Q4 2025.

For Q4 2025, Exchange Rate Effect changed N/A year-over-year to -$1000.0; the TTM value through Dec 2025 reached $137000.0, changed N/A, while the annual FY2025 figure was $137000.0, N/A changed from the prior year.
Exchange Rate Effect reached -$1000.0 in Q4 2025 per RNA's latest filing, up from -$16000.0 in the prior quarter.
In the past five years, Exchange Rate Effect ranged from a high of $115000.0 in Q2 2025 to a low of -$16000.0 in Q3 2025.